Jing Hong Selected Research

N-desulfated heparin

2/2008	[Inhibition of bFGF gene expression and tumor angiogenesis of orthotopic implantation of human gastric carcinoma by N-desulfated heparin].
1/2007	Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing Hong Research Topics

Disease

16	Neoplasms (Cancer) 03/2022 - 10/2005
14	Hypertension (High Blood Pressure) 06/2022 - 06/2002
10	Obstructive Sleep Apnea 01/2021 - 12/2011
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2012
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2007
7	Dry Eye Syndromes (Dry Eye Syndrome) 04/2020 - 01/2007
7	Insulin Resistance 12/2015 - 01/2003
6	Obesity 07/2019 - 12/2009
5	Essential Hypertension 02/2019 - 01/2003
5	Neoplasm Metastasis (Metastasis) 04/2016 - 01/2007
3	Corneal Edema 06/2022 - 01/2019
3	Diabetic Nephropathies (Diabetic Nephropathy) 03/2022 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2013
3	Fuchs' Endothelial Dystrophy 01/2022 - 04/2014
3	Proteinuria 01/2022 - 01/2015
3	Inflammation (Inflammations) 01/2020 - 01/2016
3	Dyslipidemias (Dyslipidemia) 07/2019 - 03/2011
3	Hypoxia (Hypoxemia) 03/2016 - 08/2014
3	Carcinoma (Carcinomatosis) 02/2008 - 01/2007
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 01/2022
2	Glaucoma 11/2022 - 04/2014
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 12/2017
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2021
2	Glucose Metabolism Disorders 01/2022 - 11/2020
2	Ulcer 01/2022 - 01/2021
2	Vasculitis (Vasculitides) 01/2022 - 02/2019
2	Diabetic Foot 01/2022 - 01/2021
2	Infections 10/2021 - 03/2009
2	Bronchiolitis Obliterans Syndrome 01/2021 - 04/2020
2	Corneal Opacity 01/2020 - 10/2015
2	Pain (Aches) 08/2019 - 09/2015
2	Aphakia 01/2018 - 01/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2015 - 07/2012
2	Hypercholesterolemia 04/2014 - 12/2009
2	Cataract (Cataracts) 02/2013 - 01/2011
2	Hypertriglyceridemia 03/2011 - 12/2009
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2010 - 10/2010
2	Xerophthalmia 03/2009 - 01/2007
1	Myocardial Infarction 01/2022
1	COVID-19 01/2022
1	Foot Ulcer 01/2022
1	Sleepiness 01/2022
1	Aortic Dissection 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Cognitive Dysfunction 12/2021

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2002
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2010
7	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2010
6	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 09/2019
5	Biological ProductsIBA 10/2021 - 03/2009
5	Insulin (Novolin)FDA Link 06/2016 - 01/2003
4	Oxygen (Dioxygen)IBA 06/2022 - 08/2014
3	CytokinesIBA 11/2022 - 04/2014
3	oxidized low density lipoproteinIBA 01/2022 - 12/2009
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2003
3	AldosteroneIBA 01/2022 - 11/2020
3	PotassiumIBA 01/2022 - 11/2020
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2009
3	LipidsIBA 01/2021 - 01/2015
3	Pharmaceutical PreparationsIBA 07/2020 - 01/2014
3	Therapeutic UsesIBA 01/2020 - 02/2014
3	HDL CholesterolIBA 01/2015 - 12/2009
3	CholesterolIBA 08/2014 - 01/2003
3	FurinIBA 04/2014 - 10/2012
3	Glucagon (Glukagon)FDA Link 01/2012 - 10/2005
3	Saline SolutionIBA 02/2008 - 01/2007
2	AlbuminsIBA 01/2022 - 12/2015
2	C-Reactive ProteinIBA 01/2022 - 02/2019
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2009
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	AcidsIBA 02/2020 - 09/2019
2	CreatinineIBA 02/2019 - 12/2015
2	Messenger RNA (mRNA)IBA 04/2017 - 01/2007
2	Surface-Active Agents (Surfactants)IBA 03/2016 - 09/2015
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2016 - 01/2014
2	Dihydrotachysterol (AT 10)IBA 12/2015 - 01/2007
2	Prion ProteinsIBA 10/2010 - 10/2010
2	SolutionsIBA 01/2010 - 02/2008
2	Coal (Coals)IBA 03/2009 - 01/2007
2	N-desulfated heparinIBA 02/2008 - 01/2007
2	AnticoagulantsIBA 02/2008 - 01/2007
1	Complement System Proteins (Complement)IBA 11/2022
1	ErianinIBA 03/2022
1	Antiviral Agents (Antivirals)IBA 03/2022
1	AntioxidantsIBA 03/2022
1	Pyruvate CarboxylaseIBA 03/2022
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2022
1	VaccinesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	ReninIBA 01/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022

Therapy/Procedure

12	Corneal Transplantation (Keratoplasty) 11/2022 - 01/2011
3	Therapeutics 01/2022 - 01/2017
3	Vitrectomy 01/2018 - 01/2011
2	Slit Lamp 01/2022 - 10/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 02/2014
2	Aftercare (After-Treatment) 02/2014 - 01/2007